EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 10 (Octobre 2010) Med Sci (Paris), 26 10 (2010) 869-874 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 10, Octobre 2010
Page(s) 869 - 874
Section M/S revues
DOI https://doi.org/10.1051/medsci/20102610869
Published online 15 October 2010
  1. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001 ; 194 : 1823-34. [Google Scholar]
  2. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005 ; 23 : 275-306. [Google Scholar]
  3. Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005 ; 23 : 19-28. [Google Scholar]
  4. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009 ; 227 : 221-33. [Google Scholar]
  5. Longman RS, Talal AH, Jacobson IM, et al. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 2005 ; 192 : 497-503. [Google Scholar]
  6. Sapoznikov A, Fischer JA, Zaft T, et al. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med 2007 ; 204 : 1923-33. [Google Scholar]
  7. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002 ; 17 : 211-20. [Google Scholar]
  8. Longman RS, Talal AH, Jacobson IM, et al. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004 ; 103 : 1026-9. [Google Scholar]
  9. Larsson M, Babcock E, Grakoui A, et al. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol 2004 ; 78 : 6151-61. [Google Scholar]
  10. Rodrigue-Gervais IG, Jouan L, Beaulé G, et al. Poly(I:C) and LPS innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 2007 ; 81 : 5537-46. [Google Scholar]
  11. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003 ; 187 : 1951-8. [Google Scholar]
  12. Tsubouchi E, Akbar SM, Horiike N, et al. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol 2004 ; 39 : 754-62. [Google Scholar]
  13. Granelli-Piperno A, Shimeliovich I, Pack M, et al. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J Immunol 2006 ; 176 : 991-8. [Google Scholar]
  14. Rollier C, Drexhage JA, Verstrepen BE, et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 2003 ; 38 : 851-8. [Google Scholar]
  15. Tsubouchi E, Akbar SM, Murakami H, et al. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004 ; 137 : 417-23. [Google Scholar]
  16. Averill L, Lee WM, Karandikar NJ. Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol 2007 ; 123 : 40-9. [Google Scholar]
  17. Della Bella S, Crosignani A, Riva A, et al. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology 2007 ; 121 : 283-92. [Google Scholar]
  18. Miyazaki M, Kanto T, Inoue M, et al. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol 2008 ; 80 : 980-8. [Google Scholar]
  19. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003 ; 301 : 640-3. [Google Scholar]
  20. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003 ; 424 : 743-8. [Google Scholar]
  21. Kumar H, Koyama S, Ishii KJ, et al. Cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 2008 ; 180 : 683-7. [Google Scholar]
  22. Rodrigue-Gervais IG, Rigsby H, Jouan L, et al. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol 2010 ; 184 : 3134-44. [Google Scholar]
  23. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005 ; 102 : 2992-7. [Google Scholar]
  24. Johnson CL, Owen DM, Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 2007 ; 282 : 10792-803. [Google Scholar]
  25. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004 ; 21 : 733-41. [Google Scholar]
  26. Kobayashi T, Walsh PT, Walsh MC, et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003 ; 19 : 353-63. [Google Scholar]
  27. Yamamoto M, Sato S, Hemmi H, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003 ; 4 : 1144-50. [Google Scholar]
  28. Spörri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005 ; 6 : 163-70. [Google Scholar]
  29. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 ; 21 : 685-711. [Google Scholar]
  30. Probst HC, McCoy K, Okazaki T, et al. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005 ; 6 : 280-6. [Google Scholar]
  31. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 2007 ; 25 : 71-99. [Google Scholar]
  32. Nolte MA, Leibundgut-Landmann S, Joffre O, et al. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo. J Exp Med 2007 ; 204 : 1487-501. [Google Scholar]
  33. Wilson NS, Behrens GM, Lundie RJ, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 2006 ; 7 : 165-72. [Google Scholar]
  34. Young LJ, Wilson NS, Schnorrer P, et al. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc Natl Acad Sci USA 2007 ; 104 : 17753-8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.